Transfusion Service

(P-TS-1) A Case Of A Possible Transfusion-Associated Fatality: The Continued Challenges Of Managing And Treating Patients In Sickle Cell Crisis

(P-TS-2) A Case of Paroxysmal Cold Hemoglobinuria associated with SARS-CoV2 Infection

(P-TS-3) A prospective study of blood transfusion practice in a low resource hospital setting in Sub-Saharan Africa

(P-TS-4) ABO/Rh Type Discrepancy in a Neonate Receiving Intrauterine Transfusion

(P-TS-5) Adverse Event Outcomes of 6-Day-Stored Pathogen-Reduced Platelet Transfusion

(P-TS-6) Albumin Utilization Audit at a Community Hospital

(P-TS-7) An Evaluation of Plasma Transfusion Practices: A 10-Year Retrospective Study

(P-TS-8) An Evaluation of Product Usage and Wastage After Implementation of Low-Titer Group O Whole Blood Products Issued for Patients Under Massive Transfusion Protocol

(P-TS-9) An Outbreak of Anaphylactic Reactions to Group B Platelet/Plasma and its Possible Relation to Alpha-Gal-Associated Meat Allergy

(P-TS-10) An unsupervised learning approach to identify immunoglobulin utilization patterns using electronic health records

(P-TS-11) An Unusual Case of Transfusion Related Acute Lung Injury

(P-TS-12) Anti-D development between patients with and without history of solid organ transplant

(P-TS-13) Assessment of the Rates of Positive HLA Class I Antibody Testing in Relation to Clinical and Laboratory Parameters in Patients with Platelet Refractoriness

(P-TS-14) Blood Utilization Trends Among Inpatient U.S. Medicare Beneficiaries Ages 65 and Older, During 2007-2021

(P-TS-15) Building Downtime Transfusion Label into Routine Labeling Process

(P-TS-16) Case Report: Two different patient outcomes when transfusing double apheresis RBCs from same group O donor with high titer anti-A

(P-TS-17) Characterizing the Transfusion Continuum in a Low-Resource Referral Hospital in Kenya: Developing a Protocol for Emergency Transfusions

(P-TS-18) Collecting a Pre-Operative Type and Screen Anywhere in the System

(P-TS-19) Comparison of Platelet Increment with Conventional versus Psoralen-treated Platelets suspended in Platelet Additive Solution or Plasma

(P-TS-20) Compatibility Testing Laboratory Response to Hospital Cyber-Attack

(P-TS-21) COVID-19 Transmission from Granulocyte Transfusion? A Case Report

(P-TS-22) Cryoprecipitate Usage, Policy, and Practices among Blood Banks in the United States

(P-TS-23) Decreasing the Need for AB Plasma at a Level I Trauma Center

(P-TS-24) Design of ReCePI, a Randomized, Double-Blinded, Phase III Study to Evaluate the Efficacy and Safety of Pathogen Reduced RBCs in Complex Cardiac Surgery

(P-TS-25) Developing a Tool to Assess Red Blood Cell Clearance in Vivo Utilizing Pathogen-Reduced RBCs

(P-TS-26) Diagnosis of Oh (Bombay) Phenotype in a Pregnant Patient

(P-TS-27) Do We Send It Out or Run Selected Cells? A Statistical Evaluation of Panel Efficiency

(P-TS-28) Effect of Cryopreserved Platelets on Blood Loss and Platelet Count Increment Compared with Standard Platelet Transfusion: A Systematic Review

(P-TS-29) Effect of donor and recipient characteristics on hemoglobin increments in intensive care unit patients receiving red blood cell transfusion

(P-TS-30) Evaluating hemolysis due to incompatible plasma in a rapid infuser

(P-TS-31) Evaluation of Potassium Levels in Non-irradiated and Irradiated Red Cells Units

(P-TS-32) Febrile Transfusion-Associated Circulatory Overload: HOT TACO.

(P-TS-33) Following the Disposition of Low-Titer Group O Whole Blood at a Level 1 Trauma Center

(P-TS-34) Freeze-Dried Plasma as a Treatment Option in Pre-Hospital and Emergency Settings

(P-TS-35) Group O Red Blood Cell Utilization in Group A recipients with Neonatal Congenital Diaphragmatic Hernia Surgical Repair: A Patient Blood Management Opportunity

(P-TS-36) Home transfusion: A four year post-pandemic experience at a tertiary care hospital in Spain

(P-TS-37) Hydroxocobalamin Mimicking Posttransfusion Hemolysis in Transfusion Reaction Evaluation

(P-TS-38) Impact of amotosalen/UVA treatment for pathogen reduction in platelet concentrates on transfusion efficacy in cardiac surgery

(P-TS-39) Impact to Put in Place Secondary Bacterial Culture in Order to Reduce Bacterial Contamination of Platelet Transfusions

(P-TS-40) Implementation and Quality Analysis of Pathogen Reduced Cryoprecipitated Fibrinogen Complex

(P-TS-41) Implementation of Pathogen Reduced Cryoprecipitated Fibrinogen Complex in a Pediatric Level II Trauma Center

(P-TS-42) Implementing Low Titer Group O Whole Blood: A Level 1 Trauma Center Experience

(P-TS-43) Improved Operational Efficiency With Pathogen Reduced Cryoprecipitated Fibrinogen Complex vs. CryoAHF

(P-TS-44) Improving Blood Availability in Low- and Middle-Income Countries through Drone-Based Blood Delivery: Conclusions from an International Working Group.

(P-TS-45) Improving Blood Transfusion Ordering for Patients with Sickle Cell Disease

(P-TS-46) Improving Specimen Labeling Compliance After Electronic Medical Record Transition

(P-TS-47) Improving the Frequency of Post-Transfusion Platelet Counts with Unit Tags

(P-TS-48) Increasing Platelet Transfusions Post-COVID

(P-TS-49) INTERCEPT Treatment of Contaminant Bacteria Enterobacter soli, Leclercia adecarboxylata, and Staphylococcus saprophyticus in Human Apheresis Platelets

(P-TS-50) Intravenous Drug Abuse and Alloimmunization: A Case Report of Unusually High Anti-D Antibody Titers in Rh-Negative Pregnant Female

(P-TS-51) Labor Cost Savings with Updated Standing Order Strategy

(P-TS-52) Laboratory quantification of fetal maternal hemorrhage: practice survey and scoping review

(P-TS-53) Liver Transplantation in a Highly Alloimmunized Patient with Sickle Cell Disease and Complex Blood Product Requirements

(P-TS-54) Low Rh D Alloimmunization Rate in D-negative Liver Transplant Patients Receiving D-positive Red Blood Cell transfusion Perioperatively

(P-TS-55) Major ABO-incompatible platelet transfusion is not associated with higher incidence of hospital complications in patients with intracerebral hemorrhage

(P-TS-56) Maximization Of Platelet Inventory Within A Multi-Hospital System

(P-TS-57) Minimizing Rh Immune Globulin Injections for Prenatal Patients Based on RHD Molecular Testing

(P-TS-58) Multiple rapid allo-immunizations and severe DHTR after massive transfusion of RhD-positive RBC in a RhD-negative recipient: case report and literature review

(P-TS-59) Multiple Unit Transfusion Practices at a Pediatric Hospital - Are They Really Necessary?

(P-TS-60) Neutrophil Antigen Antibodies Affect Engraftment and Secondary Graft Failure In Hematopoietic Progenitor

(P-TS-61) Outpatient Transfusions and Transfusion-Associated Circulatory Overload (TACO) Among U.S. Medicare Beneficiaries, Ages 65 and Older, During 2016-2022

(P-TS-62) Outpatient Transfusions and Transfusion-Related Acute Lung Injury (TRALI) Among U.S. Medicare Beneficiaries, Ages 65 and Older, During 2016-2022

(P-TS-63) Packed Red Blood Cell Transfusions (pRBC) in the Home Setting For Chronic Condition Patients

(P-TS-64) Pathogen-Reduced Platelet Storage for 6-Days to Mitigate Acute-On-Chronic Platelet Shortages

(P-TS-65) Performance characteristics of a new multiplex blood screening assay on a fully automated system that detects 5 mosquito-borne viruses

(P-TS-66) Platelet Inventory Strategy to Reduce Platelet Wastage and Costs in a Suburban Academic Medical Center

(P-TS-67) Platelets Transfused >5ml/kg/hr In Pediatric Patients Increases Occurrence of Allergic Transfusion Reaction

(P-TS-68) Presence of Isohemagglutinins in Group O Neonates: Potential Implications for ABO Incompatible Heart Transplants

(P-TS-69) Process Improvement to a Pediatric Massive Transfusion Protocol, a Multidisciplinary Approach

(P-TS-70) Real-World Evidence on Clinical Outcomes and Healthcare Resource Use in Patients with Sickle Cell Disease and Delayed Hemolytic Transfusion Reactions

(P-TS-71) Reduced Blood Bank Product Preparation Time and Waste with Implementation of Pathogen Reduced Cryoprecipitate

(P-TS-72) Regional and Institutional Variation in Managing Rh Disease in Mexico

(P-TS-73) Retrospective Review of Unexpected Red Cell Antibody Development After Transfusion of Non-Identical Rh Type Red Blood Cells

(P-TS-74) RH(D)-mismatched whole blood transfusions in females of childbearing potential

(P-TS-75) RhD Agnosticism: Routine Provision of RhD Unmatched Blood in the Setting of a National Blood Shortage

(P-TS-76) Safety and Efficacy of Amotosalen-UVA Pathogen Reduced Platelet Components Transfused to Mature and Premature Neonates

(P-TS-77) Safety and utility of an approach in the management of patients with RBC alloimmunization undergoing liver transplantation

(P-TS-78) Select Cells vs Secondary Panels: Is It a Coin Toss?

(P-TS-79) Severe Acute Hemolytic Transfusion Reaction in a Pregnant Patient Due to Rare Anti-Vel

(P-TS-80) Single Unit Plasma Transfusions Within A 3 Month Period At A Level 1 Trauma Hospital

(P-TS-81) Successful Surgical Management of Patient with Anti-Jk3

(P-TS-82) T Antigen Activation in Streptococcus Pneumoniae Associated Atypical Hemolytic Uremic Syndrome

(P-TS-83) The Daily Look Forward Data driven IT Model Created to assist in Blood Inventory Management in a Large Oncology Center

(P-TS-84) The Incidence of Reported Transfusion Related Acute Lung Injury (TRALI) by Blood Component: A Systematic Review and Meta-Analysis

(P-TS-85) The Rapid Expansion of the Haemoglobinopathy Patient Population in Ireland: Impact on Hospital and the National Blood Services

(P-TS-86) There’s A Form For That

(P-TS-87) To Send Out or Not to Send Out? That is the Financial Question

(P-TS-88) To Wash or Not to Wash: Managing Transfusion Expectations in a Transplant Patient with Severe IgA Deficiency

(P-TS-89) Transferring Blood Units within Our Organization Prior to Expiration Date to Prevent Wastage and Reduce Cost

(P-TS-90) Transfusion Management of an RHCE*ceMO/ceMO Patient Undergoing Liver Transplant

(P-TS-91) Transfusion of Red Cells in Pediatric Patients During ECMO Runs: A Single Center Audit

(P-TS-92) Transfusion Support for Moderate and Severe Cases of COVID-19

(P-TS-93) Transfusion Support in a Patient with Hyperhemolysis Treated with Eculizumab

(P-TS-94) Trial of INTERCEPT Fibrinogen Complex to Support Massive Transfusion Protocols

(P-TS-95) Type And Screen Orders From The OR. Can This Practice Be Improved?

(P-TS-96) Type O RBC Inventory Management Can Be Significantly Improved Via Active Monitoring, Data Sharing, and Collaboration

(P-TS-97) Vaccine-boosted convalescent plasma treatment in immunosuppressed patients with mild or moderate COVID-19

(P-TS-98) Why Two When One Will Do: A Review of the Appropriateness of Uncrossmatched Emergency Release Units at a Level II Trauma Center